Bio-Rad Laboratories (BIO) Inventory (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Inventory data on file, last reported at $770.5 million in Q1 2026.

• Inventory for Q1 2026 came in at $770.5 million, down 2.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $770.5 million (down 2.48% YoY), and the FY2025 annual result was $740.7 million, down 2.54% from the prior year.
• Inventory improved to $770.5 million in Q1 2026 per BIO's latest filing, from $740.7 million in the prior quarter.
• Over five years, Inventory peaked at $804.3 million in Q3 2024 and troughed at $605.5 million in Q1 2022.
• A 5-year average of $752.3 million and a median of $775.8 million in 2023 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2024: Inventory gained 25.7% in 2022, then fell 2.63% in 2024.
• A 5-year view of Inventory shows it stood at $719.3 million in 2022, then gained by 8.51% to $780.5 million in 2023, then retreated by 2.63% to $760.0 million in 2024, then retreated by 2.54% to $740.7 million in 2025, then increased by 4.02% to $770.5 million in 2026.
• Business Quant data shows BIO's Inventory at $770.5 million in Q1 2026, $740.7 million in Q4 2025, and $783.2 million in Q3 2025.